Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004662 | 12600466 | 2 | F | 20160514 | 20160727 | 20160727 | 20160804 | EXP | IT-PFIZER INC-2016360517 | PFIZER | 75.00 | YR | F | Y | 0.00000 | 20160804 | OT | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126004662 | 12600466 | 1 | PS | Peptazol | PANTOPRAZOLE SODIUM | 1 | Oral | UNK, QD | U | 20987 | QD | ||||||||
| 126004662 | 12600466 | 2 | SS | AMIODARONE HCL | AMIODARONE HYDROCHLORIDE | 1 | Oral | UNK, QD | U | 0 | QD | ||||||||
| 126004662 | 12600466 | 3 | SS | SEREUPIN | PAROXETINE HYDROCHLORIDE | 1 | Oral | QD | U | 0 | QD | ||||||||
| 126004662 | 12600466 | 4 | SS | TRIATEC /00116401/ | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | QD | U | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126004662 | 12600466 | 2 | Tachycardia |
| 126004662 | 12600466 | 3 | Depression |
| 126004662 | 12600466 | 4 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126004662 | 12600466 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126004662 | 12600466 | Dyspnoea | |
| 126004662 | 12600466 | Hypertensive crisis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |